Deep sedation with remimazolam plus ketamine during atrial fibrillation ablation is linked to fewer clinically relevant ...

The "Left Atrial Appendage Closure (LAAC) Market - A Global and Regional Analysis: Focus on Procedure, Product, End User, and Region - Analysis and Forecast, 2025-2035" report has been added to ...

Abbott has reported new data from its prospective, non-randomised Volt CE Mark Study, indicating that individuals treated ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Six subtle signs of heart troubles you shouldn’t ignore - These symptoms can indicate underlying heart conditions and should ...

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...

A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...